APPLIED DNA SCIENCES INC APDN Income Statement

Applied dna sciences inc (APDN)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Jun'10
Revenues:
Total revenues
4,912	5,138	5,389	4,911	3,874	4,139	3,903	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product revenues
-	-	-	-	-	-	-	-	-	-	-	-	3,060	2,549	2,538	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service revenues
-	-	-	-	-	-	-	-	-	-	-	-	1,037	1,215	1,648	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	4,097	3,765	4,186	6,530	8,145	9,090	9,008	5,673	4,247	3,365	2,721	2,804	2,608	2,315	2,036	1,597	1,481	1,655	1,854	1,844	1,545	1,167	968	858	0	0	0
Cost of revenues
1,002	956	877	808	789	1,028	1,206	1,228	1,208	1,133	1,077	1,356	1,304	1,261	1,170	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating expenses:
Selling, general and administrative
9,325	9,569	10,278	11,590	12,064	11,532	11,043	10,262	10,782	12,016	13,324	13,073	12,247	11,540	10,808	10,883	11,529	11,907	13,410	13,953	13,679	14,075	13,249	12,773	13,066	12,522	11,198	10,402	8,914	7,984	7,615	9,589	9,417	9,212	8,388	7,059	0	0	0
Research and development
2,873	2,822	2,967	2,797	2,702	2,721	2,751	2,559	2,537	2,503	2,282	2,563	3,109	3,546	3,700	4,353	3,671	2,971	2,577	1,333	1,133	1,119	1,300	1,268	1,187	1,004	692	667	582	501	432	381	329	326	268	179	0	0	0
Depreciation and amortization
299	330	390	441	477	525	547	826	864	882	887	635	642	650	706	694	647	599	490	470	463	446	442	541	490	405	321	118	159	236	313	391	379	373	367	369	0	0	0
Total operating expenses
12,498	12,721	13,635	14,829	15,245	14,778	14,342	13,648	14,185	15,403	16,494	16,272	15,999	15,736	15,215	15,932	15,848	15,479	16,478	15,758	15,275	15,642	14,992	14,584	14,743	13,932	12,212	11,188	9,656	8,722	8,362	10,362	10,127	9,911	9,025	7,608	0	0	0
LOSS FROM OPERATIONS
-8,589	-8,539	-9,124	-10,725	-12,160	-11,667	-11,646	-11,023	-10,759	-12,041	-12,820	-12,387	-13,207	-13,232	-12,199	-10,275	-8,525	-6,956	-7,853	-10,213	-11,028	-12,276	-12,271	-11,779	-12,135	-11,616	-10,175	-9,590	-8,174	-7,067	-6,507	-8,517	-8,581	-8,743	-8,056	-6,750	0	0	0
Other (expense) income:
Interest income, net
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense (including related parties interest of $25,840 and $49,310 for the three and six months ended March 31, 2019, respectively)
-151	-159	-162	0	0	0	-	-	-	-	-	-	-	-	11	12	15	11	-23	-38	-43	-43	-11	1	1	0	-	0	0	-	-	-	-	-	-	-	-	-	-
Other income (Note C)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Interest income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,283	1,944	2,837	2,458	1,944	0	0	0
Other expense, net
-281	-58	-43	-31	-44	-34	-37	-48	-35	-38	-38	-33	28	12	12	5	-51	-33	-28	-18	37	-35	123	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on conversion of Promissory notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	980	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-
Loss on change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,239	-1,723	-1,267	-908	-956	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-
Loss before provision for income taxes
-8,310	-8,045	-8,617	-10,874	-12,284	-11,743	-11,692	-11,072	-10,795	-12,078	-12,855	-12,416	-13,172	-13,211	-12,175	-10,256	-8,560	-6,978	-11,881	-13,490	-13,738	-14,603	-13,066	-14,679	-14,896	-15,273	-17,686	-15,735	-15,029	-13,445	-7,150	-9,800	-10,526	-11,580	-10,515	-8,694	0	0	0
Provision for income taxes
15	15	15	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
NET LOSS
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Less: Net (income) loss attributable to noncontrolling interest
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NET LOSS attributable to Applied DNA Sciences, Inc.
-8,316	-8,051	-8,623	-10,874	-12,284	-11,743	-11,692	-11,072	-10,795	-12,078	-12,855	-12,416	-13,172	-13,211	-12,175	-10,256	-8,560	-6,978	-11,881	-13,490	-13,738	-14,603	-13,066	-14,679	-14,896	-15,273	-17,686	-15,735	-15,029	-13,445	-7,150	-9,800	-10,526	-11,580	-10,515	0	0	0	-
Deemed dividend related to warrant modifications
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NET LOSS applicable to common stockholders
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share applicable to common stockholders-basic and diluted
-0.79	-1.12	-2.18	-0.04	-3.22	-4.25	-15.57	-0.10	-0.07	-0.12	-0.10	-0.10	-0.13	-0.16	-0.10	-0.14	-0.14	-0.13	0.07	-0.08	-0.11	-0.51	-0.15	-0.14	-0.20	-0.48	-1.50	0.00	0.00	-0.01	-0.74	0.00	0.00	0.00	-0.01	-0.01	-0.01	0.00	-0.01
Weighted average shares outstanding-basic and diluted (in shares)
3,758	2,380	-36,022	38,113	834	761	-84,948	30,112	30,112	27,674	27,363	26,374	26,351	25,427	24,082	24,075	24,072	22,542	21,489	21,444	17,362	15,456	13,857	13,569	13,470	13,164	-2,004,541	721,142	680,399	649,922	-1,630,427	594,931	583,619	490,282	-	351,962	351,395	-	-
Weighted average shares outstanding-Basic and fully diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	349,153	301,362
Product
Total revenues
2,130	2,052	2,136	1,430	1,432	1,799	1,827	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service
Total revenues
2,781	3,086	3,253	3,480	2,442	2,340	2,075	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-